Literature DB >> 25365223

TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Alessia Perino, Thijs Willem Hendrik Pols, Mitsunori Nomura, Sokrates Stein, Roberto Pellicciari, Kristina Schoonjans.   

Abstract

The bile acid-responsive G protein-coupled receptor TGR5 is involved in several metabolic processes, and recent studies suggest that TGR5 activation may promote pathways that are protective against diet-induced diabetes. Here, we investigated the role of macrophage-specific TGR5 signaling in protecting adipose tissue from inflammation and associated insulin resistance. Examination of adipose tissue from obese mice lacking macrophage Tgr5 revealed enhanced inflammation, increased chemokine expression, and higher macrophage numbers compared with control obese animals. Moreover, macrophage-specific deletion of Tgr5 exacerbated insulin resistance in obese animals. Conversely, pharmacological activation of TGR5 markedly decreased LPS-induced chemokine expression in primary macrophages. This reduction was mediated by AKT-dependent activation of mTOR complex 1, which in turn induced the differential translation of the dominant-negative C/EBPβ isoform, liver inhibitory protein (LIP). Overall, these studies reveal a signaling pathway downstream of TGR5 that modulates chemokine expression in response to high-fat diet and suggest that targeting this pathway has the potential to be therapeutically exploited for prevention of chronic inflammatory diseases and type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25365223      PMCID: PMC4348975          DOI: 10.1172/JCI76289

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  92 in total

1.  Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages.

Authors:  Katrin Haselow; Johannes G Bode; Marianne Wammers; Christian Ehlting; Verena Keitel; Laura Kleinebrecht; Anna-Kathrin Schupp; Dieter Häussinger; Dirk Graf
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

2.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.

Authors:  P Descombes; U Schibler
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

3.  GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

Authors:  Da Young Oh; Saswata Talukdar; Eun Ju Bae; Takeshi Imamura; Hidetaka Morinaga; WuQiang Fan; Pingping Li; Wendell J Lu; Steven M Watkins; Jerrold M Olefsky
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

4.  CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β.

Authors:  Zhiqi Zhang; Jennifer L Bryan; Elizabeth DeLassus; Li-Wei Chang; Weiming Liao; Linda J Sandell
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

5.  The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.

Authors:  Julia Phieler; Kyoung-Jin Chung; Antonios Chatzigeorgiou; Anne Klotzsche-von Ameln; Ruben Garcia-Martin; David Sprott; Maria Moisidou; Theodora Tzanavari; Barbara Ludwig; Elena Baraban; Monika Ehrhart-Bornstein; Stefan R Bornstein; Hassan Mziaut; Michele Solimena; Katia P Karalis; Matina Economopoulou; John D Lambris; Triantafyllos Chavakis
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Verena Keitel; Jon K Laerdahl; Lina Spomer; Eva Ellinghaus; Abdou ElSharawy; Espen Melum; Kirsten M Boberg; Thomas Manke; Tobias Balschun; Christoph Schramm; Annika Bergquist; Tobias Weismüller; Daniel Gotthardt; Christian Rust; Liesbet Henckaerts; Clive M Onnie; Rinse K Weersma; Martina Sterneck; Andreas Teufel; Heiko Runz; Adolf Stiehl; Cyriel Y Ponsioen; Cisca Wijmenga; Morten H Vatn; Pieter C F Stokkers; Severine Vermeire; Christopher G Mathew; Benedicte A Lie; Ulrich Beuers; Michael P Manns; Stefan Schreiber; Erik Schrumpf; Dieter Häussinger; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

7.  The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.

Authors:  Noémie Péan; Isabelle Doignon; Isabelle Garcin; Aurore Besnard; Boris Julien; Bingkaï Liu; Sophie Branchereau; Anne Spraul; Catherine Guettier; Lydie Humbert; Kristina Schoonjans; Dominique Rainteau; Thierry Tordjmann
Journal:  Hepatology       Date:  2013-08-19       Impact factor: 17.425

8.  The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon.

Authors:  J B J Ward; M S Mroz; S J Keely
Journal:  Neurogastroenterol Motil       Date:  2013-05-01       Impact factor: 3.598

9.  Loss of CCR5 results in glucose intolerance in diet-induced obese mice.

Authors:  Arion Kennedy; Corey D Webb; Andrea A Hill; Marnie L Gruen; Laurel G Jackson; Alyssa H Hasty
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-08-13       Impact factor: 4.310

10.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.

Authors:  Shinya U Amano; Jessica L Cohen; Pranitha Vangala; Michaela Tencerova; Sarah M Nicoloro; Joseph C Yawe; Yuefei Shen; Michael P Czech; Myriam Aouadi
Journal:  Cell Metab       Date:  2013-12-26       Impact factor: 27.287

View more
  65 in total

Review 1.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

2.  Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function.

Authors:  Sushabhan Sadhukhan; Xiaojing Liu; Dongryeol Ryu; Ornella D Nelson; John A Stupinski; Zhi Li; Wei Chen; Sheng Zhang; Robert S Weiss; Jason W Locasale; Johan Auwerx; Hening Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-05       Impact factor: 11.205

3.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

Review 4.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

Review 5.  Bile Acid Metabolism in Liver Pathobiology.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Gene Expr       Date:  2018-01-11

6.  Antibiotic effects on gut microbiota and metabolism are host dependent.

Authors:  Shiho Fujisaka; Siegfried Ussar; Clary Clish; Suzanne Devkota; Jonathan M Dreyfuss; Masaji Sakaguchi; Marion Soto; Masahiro Konishi; Samir Softic; Emrah Altindis; Ning Li; Georg Gerber; Lynn Bry; C Ronald Kahn
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

7.  Bile acid receptors link nutrient sensing to metabolic regulation.

Authors:  Jibiao Li; Tiangang Li
Journal:  Liver Res       Date:  2017-04-26

Review 8.  Resistant starches for the management of metabolic diseases.

Authors:  Laure B Bindels; Jens Walter; Amanda E Ramer-Tait
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-11       Impact factor: 4.294

Review 9.  Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.

Authors:  Bryan L Copple; Tiangang Li
Journal:  Pharmacol Res       Date:  2015-12-17       Impact factor: 7.658

10.  Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases.

Authors:  Ibrahim Choucair; Ina Nemet; Lin Li; Margaret A Cole; Sarah M Skye; Jennifer D Kirsop; Michael A Fischbach; Valentin Gogonea; J Mark Brown; W H Wilson Tang; Stanley L Hazen
Journal:  J Lipid Res       Date:  2019-12-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.